iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionGlenmede Trust Co Na
Latest Disclosed Ownership22,860 shares
Latest Disclosed Value $ 3,858,082
Glenmede Trust Co Na reports 4.37% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On February 17, 2026 - Glenmede Trust Co Na filed a 13F-HR form disclosing ownership of 22,860 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $3,858,082 USD as of December 31, 2025. The entity filed a previous 13F-HR on May 15, 2025 disclosing 21,903 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 4.37% during the quarter. The current value of the position is $2,995,803 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-17 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 22,860 957 4.37 3,858 37.74 0.0083
2025-05-15 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 21,903 51 0.23 2,801 -3.05 0.0150
2025-02-14 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 21,852 -1,835 -7.75 2,889 -16.21 0.0147
2024-11-13 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 23,687 0 0.00 3,449 6.06 0.0165
2024-08-14 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 23,687 7,517 46.49 3,251 46.57 0.0165
2024-05-15 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 16,170 1,339 9.03 2,219 10.13 0.0111
2024-02-13 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 14,831 6,219 72.21 2,015 91.26 0.0105
2023-11-14 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 8,612 -162 -1.85 1,053 -7.06 0.0060
2023-08-14 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 8,774 0 0.00 1,133 0.00 0.0064
2023-05-15 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 8,774 -1,621 -15.59 1,133 -16.94 0.0064
2023-02-14 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 10,395 -89 -0.85 1,365 11.26 0.0080
2022-11-16 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 10,484 -1,928 -15.53 1,226 -15.97 0.0077
2022-08-15 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 12,412 4,180 50.78 1,459 36.23 0.0086
2022-05-16 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 8,232 354 4.49 1,071 -10.82 0.0053
2022-02-15 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 7,878 -529 -6.29 1,201 -11.56 0.0057
2021-11-15 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 8,407 -129 -1.51 1,358 -2.72 0.0070
2021-08-16 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 8,536 0 0.00 1,396 8.72 0.0072
2021-05-18 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 8,536 -837 -8.93 1,284 -9.51 0.0069
2021-02-16 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 9,373 -163 -1.71 1,419 10.00 0.0078
2020-11-16 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 9,536 828 9.51 1,290 8.49 0.0077
2020-08-14 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 8,708 -14,552 -62.56 1,189 -57.57 0.0073
2020-05-20 2020-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND COMMON 464287556 23,260 0 0.00 2,802 0.00 0.0128
2020-02-12 2019-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND COMMON 464287556 23,260 15,137 186.35 2,802 247.21 0.0128
2019-11-14 2019-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND COMMON 464287556 8,123 150 1.88 807 -7.03 0.0037
2019-08-13 2019-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND COMMON 464287556 7,973 -850 -9.63 868 -11.88 0.0038
2019-05-14 2019-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND COMMON 464287556 8,823 -30,200 -77.39 985 -73.82 0.0045
2019-02-14 2018-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND COMMON 464287556 39,023 39,023 3,762 0.0184
2018-11-05 2018-06-30 13F/A-1 ISHARES NASDAQ BIOTECHNOLOGY COMMON 464287556 0 -8,098 -100.00 0 -100.00
2018-05-15 2018-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY COMMON 464287556 8,098 0 0.00 863 0.00 0.0036
2018-02-15 2017-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY COMMON 464287556 8,098 5,605 224.83 863 3.85 0.0036
2017-11-14 2017-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND COMMON 464287556 2,493 301 13.73 831 29.44 0.0036
2017-08-14 2017-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND COMMON 464287556 2,192 0 0.00 642 0.00 0.0031
2017-05-16 2017-03-31 13F/A-1 ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND COMMON 464287556 2,192 740 50.96 642 66.75 0.0031
2017-05-15 2017-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY COMMON 464287556 1,452 385
2017-02-14 2016-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY COMMON 464287556 1,452 -603 -29.34 385 -26.94 0.0021
2016-11-14 2016-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY COMMON 464287556 2,055 0 0.00 527 0.00 0.0032
2016-08-05 2016-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY COMMON 464287556 2,055 -205 -9.07 527 -10.53 0.0032
2016-04-28 2016-03-31 13F/A-1 ISHARES NASDAQ BIOTECHNOLOGY COMMON 464287556 2,260 -71 -3.05 589 -25.16 0.0038
2016-04-26 2016-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY COMMON 464287556 2,260 589
2016-02-11 2015-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY COMMON 464287556 2,331 -155 -6.23 787 4.52 0.0054
2015-11-12 2015-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY COMMON 464287556 2,486 248 11.08 753 -8.73 0.0055
2015-07-22 2015-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY COMMON 464287556 2,238 55 2.52 825 10.15 0.0060
2015-04-29 2015-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY COMMON 464287556 2,183 177 8.82 749 23.39 0.0055
2015-02-06 2014-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY COMMON 464287556 2,006 -105 -4.97 607 5.20 0.0048
2014-11-14 2014-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY COMMON 464287556 2,111 -586 -21.73 577 -16.62 0.0073
2014-08-13 2014-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY COMMON 464287556 2,697 1,100 68.88 692 83.55 0.0092
2014-05-07 2014-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY COMMON 464287556 1,597 80 5.27 377 9.59 0.0045
2014-01-31 2013-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY COMMON 464287556 1,517 0 0.00 344 8.52 0.0044
2013-11-14 2013-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY COMMON 464287556 1,517 75 5.20 317 26.80 0.0047
2013-08-15 2013-06-30 13F/A-1 ISHARES NASDAQ BIOTECHNOLOGY INDEX COMMON 464287556 1,442 250 0.0037
2013-08-20 2013-06-30 13F/A-2 ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND COMMON 464287556 1,442 1,442 250 0.0036
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.